The USC - Johnson & Johnson Translational Innovation Partnership Program seeks to further groundbreaking research in a wide range of therapeutic areas and will showcase emerging technologies or innovations with high potential for impact in life sciences.
It is a matching fund program with Johnson & Johnson’s Corporate Office of Science and Technology (JNJ COSAT) and USC designed to improve the development speed and relevance to industry of early stage USC technologies that hold the greatest potential to benefit patients and the healthcare system. The funded work may also contribute to additional discoveries or data that may strengthen patent coverage.
The program is open to full-time faculty at USC including research faculty, tenure-track or non-tenure track faculty. Project teams can include USC faculty, student researchers and staff members. The USC Stevens Center for Innovation encourages faculty conducting research in health sciences or medical technology to apply and will assist in investigating matching fund resources as applicants are expected to contribute 50% of the overall project funds through non-governmental funds such as departmental funds, start-up funds, or gifts. Applicants can request contribution of up to a maximum of $50,000 a year towards research projects supporting total project size of up $100K, with the possibility to renew funding once for one additional year. Larger funding can be considered in exceptional cases.
The program seeks to sponsor groundbreaking research in a wide range of therapeutic areas and should involve emerging technology or innovations of high potential impact in healthcare or healthcare delivery.